212 related articles for article (PubMed ID: 11322949)
1. IFNalpha sensitizes ME-180 human cervical cancer cells to TNFalpha-induced apoptosis by inhibiting cytoprotective NF-kappaB activation.
Suk K; Kim YH; Chang I; Kim JY; Choi YH; Lee KY; Lee MS
FEBS Lett; 2001 Apr; 495(1-2):66-70. PubMed ID: 11322949
[TBL] [Abstract][Full Text] [Related]
2. Interferon gamma (IFNgamma ) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways.
Suk K; Chang I; Kim YH; Kim S; Kim JY; Kim H; Lee MS
J Biol Chem; 2001 Apr; 276(16):13153-9. PubMed ID: 11278357
[TBL] [Abstract][Full Text] [Related]
3. Lack of requirement of STAT1 for activation of nuclear factor-kappaB, c-Jun NH2-terminal protein kinase, and apoptosis by tumor necrosis factor-alpha.
Mukhopadhyay A; Shishodia S; Fu XY; Aggarwal BB
J Cell Biochem; 2002; 84(4):803-15. PubMed ID: 11835405
[TBL] [Abstract][Full Text] [Related]
4. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation.
Watanabe K; Kubota M; Hamahata K; Lin Y; Usami I
Biochem Pharmacol; 2000 Sep; 60(6):823-30. PubMed ID: 10930537
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma induces apoptosis of lens alphaTN4-1 cells and proteasome inhibition has an antiapoptotic effect.
Awasthi N; Wagner BJ
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):222-9. PubMed ID: 14691177
[TBL] [Abstract][Full Text] [Related]
6. Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB.
Ohmori Y; Schreiber RD; Hamilton TA
J Biol Chem; 1997 Jun; 272(23):14899-907. PubMed ID: 9169460
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
Shen X; Tian Z; Holtzman MJ; Gao B
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
[TBL] [Abstract][Full Text] [Related]
8. IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway.
Fulda S; Debatin KM
Oncogene; 2002 Apr; 21(15):2295-308. PubMed ID: 11948413
[TBL] [Abstract][Full Text] [Related]
9. Regulation of CD95 (Fas/APO-1)-induced apoptosis in human chondrocytes.
Kühn K; Lotz M
Arthritis Rheum; 2001 Jul; 44(7):1644-53. PubMed ID: 11465715
[TBL] [Abstract][Full Text] [Related]
10. A caspase-3-like protease is involved in NF-kappaB activation induced by stimulation of N-methyl-D-aspartate receptors in rat striatum.
Qin Z; Wang Y; Chasea TN
Brain Res Mol Brain Res; 2000 Sep; 80(2):111-22. PubMed ID: 11038244
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
Sakai T; Kambe F; Mitsuyama H; Ishiguro N; Kurokouchi K; Takigawa M; Iwata H; Seo H
J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
[TBL] [Abstract][Full Text] [Related]
12. Interferon alpha and alcohol augment nuclear regulatory factor-kappaB activation in HepG2 cells, and interferon alpha increases pro-inflammatory cytokine production.
Szabo G; Catalano D; Bellerose G; Mandrekar P
Alcohol Clin Exp Res; 2001 Aug; 25(8):1188-97. PubMed ID: 11505050
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation.
Leverkus M; Sprick MR; Wachter T; Mengling T; Baumann B; Serfling E; Bröcker EB; Goebeler M; Neumann M; Walczak H
Mol Cell Biol; 2003 Feb; 23(3):777-90. PubMed ID: 12529384
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of interferon-gamma-activated nuclear factor-kappa B by cyclosporin A: A possible mechanism for synergistic induction of apoptosis by interferon-gamma and cyclosporin A in gastric carcinoma cells.
Beppu K; Morisaki T; Matsunaga H; Uchiyama A; Ihara E; Hirano K; Kanaide H; Tanaka M; Katano M
Biochem Biophys Res Commun; 2003 Jun; 305(4):797-805. PubMed ID: 12767900
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB.
Schmelz K; Wieder T; Tamm I; Müller A; Essmann F; Geilen CC; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2004 Sep; 23(40):6743-59. PubMed ID: 15273737
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro.
Milligan SA; Nopajaroonsri C
Anticancer Res; 2001; 21(1A):39-44. PubMed ID: 11299767
[TBL] [Abstract][Full Text] [Related]
17. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.
Manna SK; Aggarwal BB
J Immunol; 1998 Sep; 161(6):2863-72. PubMed ID: 9743347
[TBL] [Abstract][Full Text] [Related]
18. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha.
Mukhopadhyay A; Manna SK; Aggarwal BB
J Biol Chem; 2000 Mar; 275(12):8549-55. PubMed ID: 10722693
[TBL] [Abstract][Full Text] [Related]
19. Oncrasin targets the JNK-NF-κB axis to sensitize glioma cells to TNFα-induced apoptosis.
Gupta P; Dixit D; Sen E
Carcinogenesis; 2013 Feb; 34(2):388-96. PubMed ID: 23125226
[TBL] [Abstract][Full Text] [Related]
20. Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells.
Izban KF; Ergin M; Huang Q; Qin JZ; Martinez RL; Schnitzer B; Ni H; Nickoloff BJ; Alkan S
Mod Pathol; 2001 Apr; 14(4):297-310. PubMed ID: 11301346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]